Aoibhlinn O'Toole1,2, Punyanganie S de Silva1,2, Linda G Marc3, Christine A Ulysse3, Marcia A Testa3, Amanda Ting2,4, Alan Moss2,4, Josh Korzenik1,2, Sonia Friedman1,2. 1. Center for Crohn's and Colitis, Brigham and Women's Hospital, Boston, Massachusetts, USA. 2. Harvard Medical School, Harvard University, Boston, Massachusetts, USA. 3. Harvard School of Public Health, Department of Biostatistics, Boston, Massachusetts, USA. 4. Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abstract
Background: Men with inflammatory bowel disease (IBD) may have increased sexual dysfunction. To measure the prevalence of sexual dysfunction in our male patients, we aimed to develop a new IBD-specific Male Sexual Dysfunction Scale (the IBD-MSDS). Methods: We used a cross-sectional survey and enrolled male patients (N = 175) ≥18 years old who attended IBD clinics at 2 Boston hospitals. We collected information on sexual functioning via a 15-item scale. General male sexual functioning was measured using the International Index of Erectile Dysfunction (IIEF); the Patient Health Questionnaire (PHQ-9) measured depressive symptoms. Medical history and sociodemographic information were extracted from medical record review. Exploratory factor analyses (EFA) assessed unidimensionality, factor structure, reliability, and criterion and construct validity of the 15-item scale. We used regression models to identify clinical factors associated with sexual dysfunction. Results: EFA suggested retaining 10-items generating a unidimensional scale with strong internal consistency reliability, α = 0.90. Criterion validity assessed using Spearman's coefficient showing that the IBD-MSDS was significantly correlated with all the subscales of the IIEF. The IBD-MSDS was significantly correlated (construct validity) with the PHQ-9 (P < 0.001) and the composite score for active IBD cases (P < 0.05). Male sexual dysfunction in IBD was significantly associated with the presence of an ileoanal pouch anastomosis (P = 0.047), depression (P < 0.001), and increased disease activity (P = 0.021). Conclusions: We have developed and validated an IBD-specific scale to assess the psychosexual impact of IBD. This new survey tool may help physicians screen for and identify factors contributing to impaired sexual functioning in their male patients.
Background: Men with inflammatory bowel disease (IBD) may have increased sexual dysfunction. To measure the prevalence of sexual dysfunction in our male patients, we aimed to develop a new IBD-specific Male Sexual Dysfunction Scale (the IBD-MSDS). Methods: We used a cross-sectional survey and enrolled male patients (N = 175) ≥18 years old who attended IBD clinics at 2 Boston hospitals. We collected information on sexual functioning via a 15-item scale. General male sexual functioning was measured using the International Index of Erectile Dysfunction (IIEF); the Patient Health Questionnaire (PHQ-9) measured depressive symptoms. Medical history and sociodemographic information were extracted from medical record review. Exploratory factor analyses (EFA) assessed unidimensionality, factor structure, reliability, and criterion and construct validity of the 15-item scale. We used regression models to identify clinical factors associated with sexual dysfunction. Results:EFA suggested retaining 10-items generating a unidimensional scale with strong internal consistency reliability, α = 0.90. Criterion validity assessed using Spearman's coefficient showing that the IBD-MSDS was significantly correlated with all the subscales of the IIEF. The IBD-MSDS was significantly correlated (construct validity) with the PHQ-9 (P < 0.001) and the composite score for active IBD cases (P < 0.05). Male sexual dysfunction in IBD was significantly associated with the presence of an ileoanal pouch anastomosis (P = 0.047), depression (P < 0.001), and increased disease activity (P = 0.021). Conclusions: We have developed and validated an IBD-specific scale to assess the psychosexual impact of IBD. This new survey tool may help physicians screen for and identify factors contributing to impaired sexual functioning in their male patients.
Authors: Michael P Pignone; Bradley N Gaynes; Jerry L Rushton; Catherine Mills Burchell; C Tracy Orleans; Cynthia D Mulrow; Kathleen N Lohr Journal: Ann Intern Med Date: 2002-05-21 Impact factor: 25.391
Authors: Amy C Justice; Kathleen A McGinnis; J Hampton Atkinson; Robert K Heaton; Corinna Young; Joseph Sadek; Tamra Madenwald; James T Becker; Joseph Conigliaro; Sheldon T Brown; David Rimland; Steve Crystal; Michael Simberkoff Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: John W Williams; Michael Pignone; Gilbert Ramirez; Christina Perez Stellato Journal: Gen Hosp Psychiatry Date: 2002 Jul-Aug Impact factor: 3.238
Authors: Chiara Rosso; Alami Aroussi Aaron; Angelo Armandi; Gian Paolo Caviglia; Marta Vernero; Giorgio Maria Saracco; Marco Astegiano; Elisabetta Bugianesi; Davide Giuseppe Ribaldone Journal: Nurs Rep Date: 2021-04-01
Authors: Bonita Gu; Michael De Gregorio; Joseph Louis Pipicella; Niels Vande Casteele; Jane M Andrews; Jakob Begun; William Connell; Basil D'Souza; Ali Gholamrezaei; Ailsa Hart; Danny Liew; Graham Radford-Smith; Jordi Rimola; Tom Sutherland; Catherine Toong; Rodney Woods; Yang Wu; Wei Xuan; Astrid-Jane Williams; Watson Ng; Nik Sheng Ding; Susan Connor Journal: BMJ Open Date: 2021-07-01 Impact factor: 2.692